Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2016 (2016), Article ID 8794696, 4 pages
http://dx.doi.org/10.1155/2016/8794696
Case Report

Place of Colistin-Rifampicin Association in the Treatment of Multidrug-Resistant Acinetobacter Baumannii Meningitis: A Case Study

1Equipe de Recherche Epidémiologie et Résistance Bactérienne, Service de Bactériologie Hôpital, Militaire d’instruction Mohammed V, 10100 Rabat, Morocco
2Pôle Anesthésie Réanimation Hôpital, Militaire d’instruction Mohammed V, Faculté de Médecine et de Pharmacie, Université Mohammed V, BP 6203, Rabat, Morocco
3Biotechnology Laboratory (MedBiotech), Rabat Medical & Pharmacy School, Mohammed V Rabat University, BP 6203, Rabat, Morocco

Received 18 November 2015; Revised 10 February 2016; Accepted 15 February 2016

Academic Editor: Larry M. Bush

Copyright © 2016 Dahraoui Souhail et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Bassetti, F. Ginocchio, and M. Mikulska, “New treatment options against gram-negative organisms,” Critical Care, vol. 15, article 215, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. World Health Organisation, “Importance de la résistance aux antimicrobiens en santé publique,” http://www.who.int/drugresistance/AMR_Importance/fr.
  3. M. L. Durand, S. B. Calderwood, D. J. Weber et al., “Acute bacterial meningitis in adults: a review of 493 episodes,” The New England Journal of Medicine, vol. 328, no. 1, pp. 21–28, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Streharova, J. Benca, and K. Holeckova, “Comparison of postsurgical and community acquired bacterial meningitisanalysis of 372 cases within a nationwide survey,” Neuro Endocrinology Letters, vol. 28, supplement 3, pp. 7–9, 2007. View at Google Scholar
  5. M. Huttova, R. F. Freybergh, B. Rudinsky et al., “Postsurgical meningitis caused by Acinetobacter baumannii associated with high mortality,” Neuroendocrinology Letters, vol. 28, supplement 2, pp. 15–16, 2007. View at Google Scholar · View at Scopus
  6. G. Metan, E. Alp, B. Aygen, and B. Sumerkan, “Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance,” Journal of Antimicrobial Chemotherapy, vol. 60, no. 1, pp. 197–199, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Gulati, A. Kapil, B. Das, S. N. Dwivedi, and A. K. Mahapatra, “Nosocomial infections due to Acinetobacter baumannii in a neurosurgery ICU,” Neurology India, vol. 49, no. 2, pp. 134–137, 2001. View at Google Scholar · View at Scopus
  8. H.-P. Chen, C. H. Lai, Y.-J. Chan et al., “Clinical significance of Acinetobacter species isolated from cerebrospinal fluid,” Scandinavian Journal of Infectious Diseases, vol. 37, no. 9, pp. 669–675, 2005. View at Publisher · View at Google Scholar
  9. A. Rodríguez Guardado, J. A. Maradona, V. Asensi et al., “Postsurgical meningitis due to Acinetobacter baumannii: study of 22 cases and review of the literature,” Revista Clinica Espanola, vol. 201, no. 9, pp. 497–500, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. A. S. Michalopoulos, S. Tsiodras, K. Rellos, S. Mentzelopoulos, and M. E. Falagas, “Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic,” Clinical Microbiology and Infection, vol. 11, no. 2, pp. 115–121, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. A. S. Levin, A. A. Barone, J. Penço et al., “Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii,” Clinical Infectious Diseases, vol. 28, no. 5, pp. 1008–1011, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Markou, H. Apostolakos, C. Koumoudiou et al., “Intravenous colistin in the treatment of sepsis from multiresistant gramnegative bacilli in critically ill patients,” Critical Care, vol. 7, no. 5, pp. R78–R83, 2003. View at Publisher · View at Google Scholar
  13. J. Garnacho-Montero, C. Ortiz-Leyba, F. J. Jiménez-Jiménez et al., “Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP,” Clinical Infectious Diseases, vol. 36, no. 9, pp. 1111–1118, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. M. E. Falagas, K. N. Fragoulis, S. K. Kasiakou, G. J. Sermaidis, and A. Michalopoulos, “Nephrotoxicity of intravenous colistin: a prospective evaluation,” International Journal of Antimicrobial Agents, vol. 26, no. 6, pp. 504–507, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. M. E. Jiménez-Mejías, C. Pichardo-Guerrero, F. Márquez-Rivas, D. Martín-Lozano, T. Prados, and J. Pachón, “Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 21, no. 3, pp. 212–214, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Rodriguez Guardado, A. Blanco, V. Asensi et al., “Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments,” Journal of Antimicrobial Chemotherapy, vol. 61, no. 4, pp. 908–913, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. L. L. Maragakis and T. M. Perl, “Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options,” Clinical Infectious Diseases, vol. 46, no. 8, pp. 1254–1263, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. C. K. Murray and D. R. Hospenthal, “Treatment of multidrug resistant Acinetobacter,” Current Opinion in Infectious Diseases, vol. 18, no. 6, pp. 502–506, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Karaiskos, L. Galani, F. Baziaka et al., “Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series,” International Journal of Antimicrobial Agents, vol. 41, no. 5, pp. 480–483, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. E. J. Giamarellos-Bourboulis, E. Xirouchaki, and H. Giamarellou, “Interactions of colistin and rifampin on multidrug-resistant Acinetobacter baumannii,” Diagnostic Microbiology & Infectious Disease, vol. 40, no. 3, pp. 117–120, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. M. E. Pachón-Ibáñez, F. Fernández-Cuenca, F. Docobo-Pérez, J. Pachón, and Á. Pascual, “Prevention of rifampicin resistance in Acinetobacter baumannii in an experimental pneumonia murine model, using rifampicin associated with imipenem or sulbactam,” Journal of Antimicrobial Chemotherapy, vol. 58, no. 3, pp. 689–692, 2006. View at Publisher · View at Google Scholar · View at Scopus